The price cap just brings down the price to the same amount other countries pay. It's perfectly profitable for the pharmaceutical company to sell at that price.

The price cap just brings down the price to the same amount other countries pay. It's perfectly profitable for the pharmaceutical company to sell at that price. The ones who will suffer are all the middlemen between the end user and the pharmaceutical company. Who would have thought that having a single entity(not focused on profit) negotiating prices for pharmaceutical products would benefit consumers. Well, except every single country with universal healthcare.